Clinical Trial

A Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated May 20, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to assess the effect of repeated doses of itraconazole on the single dose pharmacokinetics (PK) of ABBV-722.
Trial Details
NCT Number NCT07599761
Lead Sponsor AbbVie
Conditions Healthy Volunteers
Enrollment 12 participants
Start Date 2026-05-05
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-20